Study# VX15-210-101: A Phase 2b/3, Double-blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury

  • Cybulski, George R (PD/PI)

Project: Research project

Project Details

Effective start/end date12/8/1612/8/19


  • Greenphire, Inc. (Study# VX15-210-101 // Study# VX15-210-101)
  • Vertex Pharmaceuticals Incorporated (Study# VX15-210-101 // Study# VX15-210-101)